INDV
Indivior PLC Ordinary SharesNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$4.51B
P/E Ratio
19.55
EPS
$1.95
Beta
1.17
52W High
$41.00
52W Low
$13.45
50-Day MA
$35.46
200-Day MA
$31.68
Dividend Yield
—
Profit Margin
19.50%
Forward P/E
12.47
PEG Ratio
—
About Indivior PLC Ordinary Shares
Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company is headquartered in North Chesterfield, Virginia.
Fundamentals
| Revenue (TTM) | $1.29B |
| Gross Profit (TTM) | $1.10B |
| EBITDA | $475.00M |
| Operating Margin | 46.10% |
| Return on Equity | 12.20% |
| Return on Assets | 22.70% |
| Revenue/Share (TTM) | $10.32 |
| Book Value | $-1.18 |
| Price-to-Book | 145.25 |
| Price-to-Sales (TTM) | 3.49 |
| EV/Revenue | 3.749 |
| EV/EBITDA | 13.66 |
| Quarterly Earnings Growth (YoY) | 82.00% |
| Quarterly Revenue Growth (YoY) | 19.20% |
| Shares Outstanding | $118.20M |
| Float | $110.11M |
| % Insiders | 4.31% |
| % Institutions | 106.86% |
Historical Volatility
HV 10-Day
47.33%
HV 20-Day
37.42%
HV 30-Day
35.45%
HV 60-Day
42.28%
HV Rank
43.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($51.50 target)
1
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026